Icu Medical — Q4 2024 Earnings Presentation

4 slides from Icu Medical's earnings presentation, Feb 27, 2025

Slide 1: ICU Medical, Inc Q4 2024 Conference Call Presentation
ICU Medical, Inc Q4 2024 Conference Call Presentation February 27, 2025 1
Slide 2: Disclosures
Disclosures > Any statement concerning Management’s expectation with respect to future results is a forward-looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to be a rep
Slide 3: 2023-2024 Adjusted Revenue
2023-2024 Adjusted Revenue In $Millions Tracheostomy 2023 2023 2023 2023 2023 2024 2024 2024 2024 2024 Vascular Access Q1 Q2 Q3 Q4 Total Q1 Q2 Q3 Q4 Total Consumables 236 237 242 254 969 244 262 265 268 1,039 YoY Growth -2% -2% -4% 5% -1% 3% 10% 9% 6% 7% YoY Growth (FXN) 1% -1% -5% 4% 0% 3% 11% 9% 6
Slide 4: 2025 Guidance & Modeling Assumptions
2025 Guidance & Modeling Assumptions In $Millions except per share amounts Excluding JV Transaction Expected Impacts from JV Transaction Post JV Transaction (assuming Q2 closing) Adj EBITDA 1 $395m to $425m ($15m) to ($20m) $380m to $405m 1 Adj EPS $6.55 to $7.25 Neutral $6.55 to $7.25 Revenue Growt